Skip to main content

Table 2 Characteristics of the cancer survivors

From: Factors to improve distress and fatigue in Cancer survivorship; further understanding through text analysis of interviews by machine learning

Variables

Total

N = 322

Distress < 4

n = 176

Distress ≥4

n = 146

p-value

Age, median (range)

50 (25–79)

51 (32–79)

49 (25–73)

0.043

  < 50 years

261 (81.1%)

73 (41.5%)

78 (53.4%)

 

  ≥ 50 years

61 (18.9%)

103 (58.5%)

68 (46.6%)

 

Sex

   

0.418

 Male

8 (2.5%)

6 (3.4%)

2 (1.4%)

 

 Female

314 (97.5%)

170 (96.6%)

144 (98.6%)

 

Time from end of treatment

   

0.277

  < 6 months

227 (70.5%)

129 (73.3%)

98 (67.1%)

 

  ≥ 6 months

95 (29.5%)

47 (26.7%)

48 (32.9%)

 

Cancer types

   

0.770

 Breast cancer

277 (86.0%)

150 (85.2%)

127 (87.0%)

 

 Others

45 (14.0%)

26 (14.8%)

19 (13.0%)

 

Cancer stages

   

0.646

 Early (I - II)

242 (75.2%)

130 (73.9%)

112 (76.7%)

 

 Advanced (III - IV)

80 (24.8%)

46 (26.1%)

34 (23.3%)

 

Op

   

0.764

 Not done

11 (3.4%)

7 (4.0%)

4 (2.7%)

 

 Done

311 (96.6%)

196 (96.0%)

142 (97.3%)

 

Chemotherapy

   

0.140

 Not done

139 (43.2%)

83 (47.2%)

56 (38.4%)

 

 Done

183 (56.8%)

93 (52.8%)

90 (61.6%)

 

Radiotherapy

   

0.533

 Not done

39 (12.1%)

19 (10.8%)

20 (13.7%)

 

 Done

283 (87.9%)

157 (89.2%)

126 (86.3%)

 

Other treatment

   

0.456

 Not done

154 (47.8%)

88 (50.0%)

66 (45.2%)

 

 Donea

168 (52.2%)

88 (50.0%)

80 (54.8%)

 

Comorbidities

   

0.566

 No

241 (74.8%)

129 (73.3%)

112 (76.7%)

 

 Yes

81 (25.2%)

47 (26.7%)

34 (23.3%)

 

Smoking

   

0.865

 No

292 (90.7%)

161 (91.5%)

131 (89.7%)

 

 Past

22 (6.8%)

11 (6.2%)

11 (7.5%)

 

 Current

8 (2.5%)

4 (2.3%)

4 (2.7%)

 

Drinking

   

0.368

 No

299 (92.9%)

166 (94.3%)

133 (91.1%)

 

 Yes

23 (7.1%)

10 (5.7%)

13 (8.9%)

 

Psychological counseling

   

0.012

 No

284 (88.2%)

163 (92.6%)

121 (82.9%)

 

 Yes

38 (11.8%)

13 (7.4%)

25 (17.1%)

 

Working

   

0.111

 No

260 (80.7%)

136 (77.3%)

124 (84.9%)

 

 Yes

62 (19.3%)

40 (22.7%)

22 (15.1%)

 

Married or living with a partner

   

0.161

 No

257 (79.8%)

146 (83.0%)

111 (76.0%)

 

 Yes

65 (20.2%)

30 (17.0%)

35 (24.0%)

 

Caregiver

   

< 0.001

 None or non-family

60 (18.6%)

20 (11.4%)

40 (27.4%)

 

 Family member

262 (81.4%)

156 (88.6%)

106 (72.6%)

 

Pregnancy plan

   

1.000

 No

317 (98.4%)

173 (98.3%)

144 (98.6%)

 

 Yes

5 (1.6%)

3 (1.7%)

2 (1.4%)

 

Living a long distance

   

0.023

 No

304 (94.4%)

161 (91.5%)

143 (97.9%)

 

 Yes

18 (5.6%)

15 (8.5%)

2 (1.4%)

 

Initial scoresb

 EQ-VAS

64 ± 19

67 ± 19

59 ± 18

< 0.000

 Distress

3.7 ± 2.5

1.7 ± 1.1

6.0 ± 1.6

< 0.000

 Fatigue

4.4 ± 2.4

3.6 ± 2.1

5.5 ± 2.3

< 0.000

 Pain

2.4 ± 2.3

1.9 ± 1.9

3.1 ± 2.5

< 0.000

 Insomnia

3.1 ± 2.8

1.9 ± 2.0

4.6 ± 2.8

< 0.000

 Anxiety

2.9 ± 2.7

1.3 ± 1.5

4.8 ± 2.7

< 0.000

 Depression

2.8 ± 2.8

1.1 ± 1.5

4.8 ± 2.7

< 0.000

Scores at 1 monthb

 EQ-VAS

74 ± 16

77 ± 14

70 ± 17

< 0.000

 Distress

2.6 ± 1.8

2.1 ± 1.6

3.3 ± 1.8

< 0.000

 Fatigue

3.3 ± 2.3

3.0 ± 2.3

3.8 ± 2.3

0.002

 Pain

1.8 ± 2.1

1.6 ± 1.9

2.2 ± 2.2

< 0.000

 Insomnia

1.9 ± 2.4

1.1 ± 1.7

2.9 ± 2.7

< 0.000

 Anxiety

1.7 ± 1.9

0.9 ± 1.4

2.6 ± 2.1

< 0.000

 Depression

1.6 ± 2.0

0.9 ± 1.4

2.6 ± 2.3

< 0.000

Number of improved patients

 EQ-VAS

197 (61.2%)

102 (58.0%)

95 (65.1%)

0.234

 Distress

182 (56.5%)

58 (33.0%)

124 (84.9%)

< 0.000

 Fatigue

188 (58.4%)

94 (53.4%)

94 (64.4%)

0.061

 Pain

157 (48.8%)

79 (44.3%)

79 (54.1%)

0.101

 Insomnia

168 (52.2%)

83 (47.2%)

85 (58.2%)

0.062

 Anxiety

172 (53.4%)

72 (40.9%)

100 (68.5%)

< 0.000

 Depression

165 (51.2%)

61 (34.7%)

104 (71.2%)

< 0.000

  1. aMost of patients with other treatment had hormonal therapies for breast cancer except radio-frequency ablation for one patient with liver cancer. bContinuous variables were represented by mean ± standard deviation